Biolife Solutions (BLFS) Shares Outstanding (Weighted Average) (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $47.8 million as the latest value for Q4 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.66% to $47.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.8 million, a 3.66% increase, with the full-year FY2025 number at $47.8 million, up 3.66% from a year prior.
- Shares Outstanding (Weighted Average) was $47.8 million for Q4 2025 at Biolife Solutions, roughly flat from $47.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $47.8 million in Q4 2025 to a low of $33.2 million in Q1 2021.
- A 5-year average of $43.8 million and a median of $43.5 million in 2023 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): skyrocketed 58.19% in 2021, then increased 1.64% in 2023.
- Biolife Solutions' Shares Outstanding (Weighted Average) stood at $38.5 million in 2021, then grew by 10.33% to $42.5 million in 2022, then increased by 2.91% to $43.7 million in 2023, then increased by 5.37% to $46.1 million in 2024, then rose by 3.66% to $47.8 million in 2025.
- Per Business Quant, the three most recent readings for BLFS's Shares Outstanding (Weighted Average) are $47.8 million (Q4 2025), $47.6 million (Q3 2025), and $47.5 million (Q2 2025).